Agenus Inc., a scientific-phase biotechnology corporation, discovers and develops therapies to activate the human body's immune procedure against cancer and infections in the United States and internationally. It offers Retrocyte Display screen, an antibody expression platform for that identification of thoroughly human and humanized monoclonal ant